The test is to identify the risk to developing serious complications to COVID-19 ie pneumonia and therefore require ventilation. It is not a risk prediction for someone acquiring COVID-19 - the company has not stated that! It would be a niche market but holds value in the current market if they have proof of concept. Even with a potential vaccine breakthrough- vaccination of the general public on a global scale would take 12+ months!
Do not underestimate the hysteria of the wealthy population- a peace of mind test for business and the wealthy is but a drop in the bucket.
News: GTG Genetic Technologies Says Successful Prototype Polygenic Risk Score For Covid-19 Created, page-19
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
